跳至主要内容
临床试验/CTRI/2024/02/063334
CTRI/2024/02/063334招募中4 期

Prospective interventional study to explore the efficacy of homoeopathic medicines in Glaucoma using the Glaucoma quality of life-15 (GQL-15)Â questionnaire

DR RAJENDRA PATEL1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2024年3月1日最近更新:

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
70
试验地点
1
主要终点
To study the effectiveness of individualized Homoeopathic medicines in the management of Glaucoma

研究概览

简要总结

Glaucoma is very common problem prevalent worldwide as well as in india. It is one of the leading cause for the blindness. Homoeopathic medicines acts well in cases of glaucoma. In order to see the utility of Homoeopathic medicines in glaucoma this study is taken up.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
1.00 Day(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Cases pre-diagnosed or with clinical presentation of Glaucoma will be selected irrespective of age and gender.

排除标准

  • Acute congestive glaucoma which require surgical intervention.

结局指标

主要结局

To study the effectiveness of individualized Homoeopathic medicines in the management of Glaucoma

时间窗: Cases will be evaluated at baseline and at the end of 3 months/12 weeks treatment

次要结局

  • To study the utility of Kent repertory in Glaucoma

研究者

发起方
DR RAJENDRA PATEL
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

DR RAJENDRA PATEL

SAT KAIVAL EYE HOSPITAL

研究点 (1)

Loading locations...

相似试验